ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 179 filers reported holding ARCUS BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 2.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $270 | -17.7% | 15,038 | -6.8% | 0.02% | -19.2% |
| Q2 2023 | $328 | -23.0% | 16,136 | -30.9% | 0.03% | -16.1% |
| Q1 2023 | $426 | +101.9% | 23,335 | +128.5% | 0.03% | +72.2% |
| Q4 2022 | $211 | -99.9% | 10,214 | -35.0% | 0.02% | -52.6% |
| Q3 2022 | $411,000 | -8.7% | 15,720 | -11.6% | 0.04% | -7.3% |
| Q2 2022 | $450,000 | +75.8% | 17,775 | +119.3% | 0.04% | +412.5% |
| Q1 2022 | $256,000 | – | 8,105 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |